SCHEMBL31609620

SCHEMBL31609620

CC(C)(C)OC(=O)N(Cc1ccccc1)c1cncc(Cc2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.39
STAT5B P51692 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
TSPO P30536 1/20 0.39
HTR2C P28335 1/20 0.39
SLC6A4 P31645 1/20 0.39
GRM2 Q14416 1/20 0.38
GAA P10253 1/20 0.38
TSHR P16473 1/20 0.38
POLB P06746 1/20 0.38
MCL1 Q07820 1/20 0.38
F2 P00734 2/20 0.37
FDPS P14324 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
PPARG P37231 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31609599 0.86 AKT1 (0.39) AKT1STAT5BHDAC3HDAC1HDAC2
SCHEMBL4194363 0.85 CHRM2 (0.43) GRM2POLBF2CHRM2CHRM1
SCHEMBL31609600 0.81 F2 (0.32) AKT1STAT5BHDAC3HDAC1HDAC2
SCHEMBL31609582 0.76 HDAC1 (0.41) AKT1STAT5BHDAC3HDAC1HDAC2
SCHEMBL7473118 0.76 LTB4R2 (0.49) AKT1STAT5BHDAC3HDAC1HDAC2
SCHEMBL22042475 0.75 TRPM8 (0.45) AKT1STAT5BHDAC3HDAC1HDAC2
SCHEMBL23912387 0.75 NR1H4 (0.46) AKT1HDAC3HDAC1HDAC2NCOR2
SCHEMBL4315970 0.75 PTGES (0.54) AKT1STAT5BHDAC3HDAC1HDAC2
SCHEMBL19922245 0.75 AKT1 (0.47) AKT1STAT5BHDAC3HDAC1HDAC2
SCHEMBL5906827 0.75 CHRM2 (0.50) AKT1HDAC3HDAC1HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12486232-B2 Method for preparing meta-functionalized pyridine compound NANKAI UNIVERSITY (CN) 2025-12-02 US disclosed
US-20250179021-A1 Method For Preparing Meta-Functionalized Pyridine Compound CNBM RESEARCH INSTITUTE FOR ADVANCED GLASS MATERIALS GROUP CO., LTD. (CN) 2025-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12486232-B2 Method for preparing meta-functionalized pyridine compound GAPVD1, SKP1, PDXK AKT1 4073/4885STAT5B 3999/4885HDAC3 4471/4885
US-20250179021-A1 Method For Preparing Meta-Functionalized Pyridine Compound GAPVD1, SKP1, PDXK AKT1 4073/4885STAT5B 3999/4885HDAC3 4471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.